MDxHealth Targets LDTs, US Market as Part of Makeover

In its new iteration, the company, which had been called OncoMethylone Sciences until last month, will be developing its own assays for launch in CLIA labs in the US.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories